Fig. 4From: Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort reportAge to entry into ELFC-MLD levels for LI-MLD and J-MLD patients in the HSCT cohort. Numbers preceding each line refer to the Patient ID (see Tables 1 and 2). Circles represent time at entry into a respective level. Each line ends at most recent follow-up. Some patients had evaluable expressive language function data prior to HSCT. See Fig. 1 for ELFC-MLD level definitions. Patients were labeled symptomatic at the time of HSCT if they exhibited any clinical manifestation of MLDBack to article page